The China tuberculosis clinical trials consortium network: a model for international TB clinical trials capacity building.

ABSTRACT:

Background

With the second largest tuberculosis (TB) burden globally, China is committed to actively engage in international TB clinical trials to contribute to global TB research. However, lack of research capacity among local sites has been identified as a barrier.

Main text

The China Tuberculosis Clinical Trials Consortium (CTCTC) was initiated by Beijing Chest Hospital with investment from the US National Institutes of Health and technical support from Family Health International 360 in 2013, as a nationwide collaborative clinical trial network to strengthen selected clinical site research capacity and attract TB clinical trials. The program aims to: 1) recruit leading hospitals that care for TB patients; 2) conduct on-site assessment to identify capacity gaps and needs

SUBMITTER: Liu YH 

PROVIDER: S-EPMC7229594 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature